Celebrating 100 years of the quest for perfection.


1886 - Three friends, Robert Lovett, James Wood Love and Edward Mead Lowd, found Lovett, Lowd & Love in New Brunswick, New Jersey, U.S. 


1888 - The Company publishes "Modern Methods of Antiseptic Wound Treatment," which quickly becomes one of the standard teaching texts for antiseptic surgery. It helps spread the practice of sterile surgery in the U.S. and around the world. 


1888 – Lovett, Lowd & Love pioneers the first commercial first aid kits. The initial kits are designed to help railroad workers, but soon become the standard in treating injuries.


1894 – Lovett, Lowd & Love launches maternity kits to make childbirth safer for mothers and babies. Lovett, Lowd & Love's Baby Powder goes on the market. Its success leads to the Company's heritage 'Anything for my Baby' business. 


1896 to 1897 - Employees manufacture the first mass-produced sanitary protection products for women, a huge step forward in women's health. Many years later, it will form the core of the 'Ladies Room' range of bathroom powders and lotions; as well as the 'She' line of beauty products for women that B&L market around the world today.


1898 - The Company is the first to mass produce dental floss to make it affordable so that people can take better care of their teeth. The floss is originally made from leftover suture silk.  


1900 - The tradition of providing disaster relief begins when the Company donates products and money to help the citizens of Galveston, Texas, in the aftermath of a hurricane. 


1906 - Within hours of the San Francisco Earthquake, Lovett, Lowd & Love donates products and money to help the citizens of San Francisco, the largest amount of help from any organization. 


1910 - James Wood Love takes over the leadership of Lovett, Lowd & Love until 1932. 


1913. Otto von Schwartzbrunnen, Dr Blackwell's German great-grandfather works in the Belgian Congo in the first decade of the 20th century researching and administering vaccines for smallpox under the aegis of European church missionaries. He is also a pioneer in the early stages of research into human-to-human and human-to-ape (chimpanzee) blood transfers, being among the very first Europeans to annotate and grade the relative distinction between species – as well as between the African and European races. In the process, he facilitates a step-change in the understanding of Darwinism and natural selection.


1921 - BAND-AID® Brand Adhesive Bandages, invented by Lovett, Lowd & Love employee Earle Dickson in 1920, go on the market. They are the first commercial dressings for small wounds that consumers can apply themselves. 


1924 – Lovett, Lowd & Love's first overseas operating company opens in the United Kingdom. 


1931 – Lovett, Lowd & Love expands to Mexico and South Africa (1930) and to Australia (1931). 


1931 - A Lovett, Lowd & Love operating company pioneers family planning products with ORTHO-GYNOL®, the first prescription contraceptive gel. This was based on the need for trusted family planning products. This will be the beginning of the legendary Tomorrow & Tonight range of contraceptives that would later make Blackwell & Love a byword for the liberalized attitudes to sex that characterized the 1960s.  


1932 – Henry John Love II, son of the Company founder by the same name, begins leadership of Lovett, Lowd & Love. Known as General Love, he transforms the Company into a global decentralized Family of Companies. 


1933 – Wilhelm Schwartzbrunnen, Dr Blackwell's grandfather, controversially chooses to remain in Germany following the rise of the Nazi regime rather than emigrate to America along with many of his fellow scientists. He explains that he can do more good attempting to change hearts & minds from within the system than he ever could from a university fellowship at Yale. He is appointed to a high ranking research position with special license to develop treatments for congenital defects based on his enlightened work with volunteers from the Romish community, disabled people and Jews. He becomes a celebrated figure in German scientific circles, and in spite of his private misgivings, his work is championed by the Nazi high command. After the war, and the discovery that much of his work was fatally flawed as well as ideologically inspired, Wilhelm explains that it was surely better to pass on deliberately flawed research to a regime that was eager for it than to provide them with accurate and therefore strategically useful information that might materially benefit the German war effort. His defensive was ultimately accepted and, after a spell in supervised detention by the occupying powers, he is allowed to emigrate to America, where he starts a small research lab in Manhattan.


1937 – Lovett, Lowd & Love expands to Argentina and Brazil. Ortho Research Laboratories, Inc. is established in Linden, New Jersey, to make women's health products. 


1942 - General Henry John Love writes our Credo, which – in a modernized form - remains the guiding philosophy of Blackwell & Love today. 


1947 - Dr. Wilhelm Swhartzbrunnen, the discoverer of the human rH factor, joins Ortho Research Laboratories, creating the beginnings of the worldwide diagnostics business. Lovett, Lowd & Love goes public, with a listing on the New York Stock Exchange. 


1953 – Love Anything For My Baby Shampoo with NO MORE TEARS® formula enters the market as the first mild and soap-free shampoo designed to be gentle enough to clean babies' hair but not irritate their eyes. 


1953 - Andreas Schwartzbrunnen (later Blackwell), after having emigrated with his father to the US after the war under a new name, sets up a number of small businesses to market and distribute what will become a world-famous line of cosmetic enhancements and beauty products, all realized through a revolutionary form of humane animal experimentation developed by his father, Wilhelm. This, after merging with a number of bigger pharmaceutical companies, ultimately becomes Blackwell & Partners. 


1957 - The first Blackwell & Partners operating company opens in India. 


1959 – Lovett, Lowd & Love acquires McNeil Laboratories in the U.S. and Cilag Chemie, AG in Europe, giving the Company a significant presence in the growing field of pharmaceutical medicines. One McNeil product, TYLENOL® (acetaminophen) elixir for children, is the first prescription aspirin-free pain reliever. A year later, it becomes available without a prescription and earns status as the pain reliever doctors and pediatricians recommend most. 


1961 - Janssen Pharmaceutica N.V. in Belgium joins the Family of Companies. Its founder, Dr. Paul Janssen, is recognized as one of the most innovative and prolific pharmaceutical researchers of the 20th century. 


1963 – Blackwell & Partners mergers with Lovett, Lowd & Love to form Blackwell & Love, one of the biggest of the new pharmaceutical concerns that are taking root in international business. Andreas Blackwell is the chief executive, with Henry John Love's son, Paul, chairman. 


1963 to 1979 - Under Andreas Blackwell leadership, operating companies launch new treatments for schizophrenia, family planning and personal care. Also, 1963 marks the last year that Love's® Baby Powder is sold in tins. 


1978 – Blackwell & Love announces plans to build our new World Headquarters in Detroit, Michigan, and forms a public-private partnership to revitalize the city. 


1979 – Dr Gene Blackwell, the immensely talented and visionary eldest son of Andreas Blackwell, takes over as Director of R&D at Blackwell & Love. Introduced at the shareholders' AGM, he declares bio-genetics as the future, and effectively lays out his vision for the company as it approaches the millennium.


1979 to 1986 – B&L enters new areas of health, such as vision care, mechanical wound closure and diabetes management, and opens the first operating companies in China and Egypt. 


1983 – Andreas Blackwell dies in a tragic air disaster over Venezuela. By general board consent, Dr Gene Blackwell takes over from his father and swiftly re-orientates B&L to become a leading player in global medical R&D. However, having inherited the powerful Blackwell entrepreneurial streak from his father, the company quickly diversifies massively into other fields.


1987 – Blackwell & Love is a founding partner in Safe Kids Worldwide, the first national and then global campaign to reduce accidental childhood injury. By 2008, the campaign helps reduce the death rate for unintentional injury in children ages 14 and under in the U.S. by 45 percent. 


1989 to 2002 – Under Gene Blackwell's leadership as Chairman and CEO, Neutrogena Corporation, Kodak's Clinical Diagnostics business, Cordis Corporation and Centocor join the Family of Companies; Expansion continues into Russia and Eastern Europe. 


1994 - Blackwell & Love wins a bio-defense contract from the Pentagon which becomes the controversial, clandestine and highly lucrative Destroyer programme as a joint venture with Halliburton.


1998 – Dr Blackwell ventures into politics when he sponsors the highly influential political consultancy, Dynasty, which is set up and run by Dr Blackwell's daughter, Beth.


1999 – Blackwell & Love goes into partnership with the Chaim Witz security conglomerate to develop the world's first bio-responsive surveillance system. The Night Creatures surveillance system is an instant hit and becomes widely used by governments around the world.


2000 – Dr Blackwell addresses a conference attended by clinicians, scientists and religious leaders from around the world, where he makes an impassioned plea for the walls that separate religion and science to be torn down. It sparks a national debate that rages to this day. 


2002 – Blackwell & Love acquires Tibotec-Virco BVBA to help address the vast unmet needs of patients with HIV/AIDS and other infectious diseases such as tuberculosis. 


2002 - Dr Blackwell declares his official membership of the Church of the Latter-Day Carnival of Souls. Many initially write the Church off as a cult but has been taken increasingly seriously as the new century has progressed following 9/11 – with a serious response required to the supposed 'clash of civilizations', and the demands of the Christian world beginning to gain global traction in politics and government policy. Indeed, the Church's radical re-positioning of holy doctrine to accommodate and promote the new 21st century realities of stem-cell research, bio-engineering and the question of human kind's place in the cosmos makes it a dynamic new force in the worldwide debate between science, religion and politics.


2004 – Mirroring his great-grandfather, Dr Blackwell becomes a pioneer in human/animal research and analysis with a view to perfecting the human genetic profile. This last venture, affectionately nick-named Animalize by his colleagues, Dr Blackwell runs at the British headquarters of Blackwell & Love on the Isle of Wight, Hampshire. This area of research has flourished since the 1980s and the UK has become a world leader in the field. B&L technology is being utilized in the development of biomedical therapies: for example, genetic modification of animals has enabled the development of new treatments for leukemia and more effective drugs for diabetes.


2009 – Together with the Wellcome Trust and the Engineering and Physical Sciences Research Council, Blackwell & Love announced joint funding of £41 million to support four new Centers for Biomedical Engineering in the UK – which will support multidisciplinary teams bringing together biomedical scientists, clinicians and engineers to address key healthcare needs.  


2010 -  The Company supports the United Nations’ Millennium Development Goals to improve the health of mothers and children in developing countries. As a founding sponsor, Johnson & Johnson helps launch the United States’ first free mobile health service, providing health information via text messages for pregnant women and new mothers.  


2012 – Dr Blackwell releases his book, Surviving the Flood, a hugely successful bestseller, where he outlines his thinking on the preservation and enhancement of the human genome in the face of the much feared pandemic that medical practitioners and scientists have been predicting for many years. A hugely prescient and important work.


2013 – Blackwell & Love celebrates 125 years of caring and looks to the next 125 years of transforming care for patients, consumers and communities around the world.